Why not ask a technician to promote better prescribing?
|
It is not just pharmacists who have a role in the national initiative to promote the better hospital use of antimicrobials. This article describes the work of a technician who has analysed prescribing and helped influence drug use |
By Brian Moulder
|
|
Focus on technicians series |
Mr Moulder is senior pharmacy technician for drug use evaluation at North Tees and Hartlepool NHS Trust and can be contacted by e-mailing: Brian.Moulder@nth.nhs.uk
|

Brian Moulder – analysing prescribing patterns at North
Tees and Hartlepool NHS Trust |
When the North Tees and Hartlepool NHS Trust received money from the
Department of Health last year as part of the national initiative to
promote the prudent use of antimicrobials, managers thought about appointing
a part-time pharmacist to evaluate and influence antimicrobial prescribing
at the trust. They then thought again — and decided to have a
senior pharmacy technician take on the work full-time, combining it
with the role of analysing the prescribing of other drugs.
This article describes how the drug use evaluation technician established
standard operating
procedures (SOPs) for analysing prescribing and
adjusting policies and formularies to promote more effective prescribing
at the two hospital sites that make up the trust.
Establishing procedures
At the time that the project started, there were no set procedures
in place at the trust to analyse prescribing patterns or adjust the
trusts’ policies or formulary. If better drug use (both of antimicrobials
and of other medicines) were to be promoted, it was important that
these be set up.
It was decided that removing
co-proxamol from the formulary would be used as a “test case” to
set up SOPs. Removing this drug was not particularly contentious, and
so analysing the stages involved would enable basic SOPs to be built
up relatively easily. These could then be used as a basis for making
more controversial and larger scale adjustments to prescribing (such
as those involving antimicrobials).
In order to draw up the SOPs, the processes involved in removing co-proxamol
from the trusts formulary were mapped and documented in detail from
start to finish. They seemed to fit into the categories of:
· Identifying the scope of an evaluation
· Obtaining information on prescribing patterns
· Developing solutions to form the basis of a report to the Drugs and
Therapeutics Committee (DTC)
· Implementing the decision of the DTC
· Auditing the implementation
· Other activities
Further information about these stages is set out below.
Identifying the scope

Checking for antibiotic resistance in the laboratory: linking
in trust policies with resistance data and national guidelines
is underway at North Tees and Hartlepool NHS Trust |
Any member of staff at the hospital trust or primary care trust served
by the hospital trust can suggest an evaluation to be carried out.
Priority is given to those that relate to rationalising antibiotic
use, enhancing patient safety and/or improving the cost-effectiveness
of prescribing.
Once it has been decided to carry out an evaluation, its scope (ie,
whether it is to apply to just one ward, several specialities, across
a whole hospital site or the whole trust and associated primary care
trusts) needs to be assessed. Different resources will be required,
depending on how widely prescribing is to be influenced. If the time
of pharmacists or other technicians is likely to be required (for example
to visit some of the primary care trusts) then this needs to be planned
early on.
This early stage of the process also
provides an opportunity for identifying any problems areas or potential
barriers (such as where particular drugs are used seemingly inappropriately
more at one site than
another). If these sort of issues can be resolved at the outset it
will make the rest of the process more efficient.
Obtaining information
The next stage is to use the available resources, mainly the pharmacy
computer system (ASCribe is used at the North Tees and Hartlepool NHS
Trust) to investigate current prescribing patterns. Prescribing of
the particular drug concerned is first analysed across the whole trust.
Data is then broken down to ward and consultant level. One of the main
aims at this stage is to establish a baseline figure of prescribing
patterns so that the effects of implementation of policies or formulary
changes can be audited at a later date.
Information about prescribing patterns can also be obtained from discussions
with medical staff at the hospital trust. Opening up channels of communication,
making communication “two-way” and having people “on
board” at this early stage will help a lot later when it comes
to implementing policies.
Staff at primary care trusts should also be asked for details about
prescribing trends. This can help reinforce trust decisions; for example,
when I approached prescribing advisors at the four primary care trusts
served by North North Tees and Hartlepool NHS Trust they were all actively
trying to discourage the prescribing of co-proxamol. Contacting prescribing
advisors at an early stage is also important because changes made to
prescribing habits in secondary care clearly have a “knock on” effect
in primary care.
Developing solutions
Searching the internet for guidance produced by other hospitals or
relevant groups is the next stage in the process. This might show that
the prescribing trends found are appropriate or suggest that practices
should be changed. Consultants and clinicians are invited to contribute
to the evidence gathering. They (along with primary care prescribing
advisors) are also asked to suggest ways in which policies could be
amended to match the current evidence base.
Several different factors need to be taken into consideration when
proposing solutions. The DUE process will question any decision based
on cost alone or benefit alone. The overall picture must embrace
evidence-based practice, best practice, personal experience of specialists,
patient choice and cost effectiveness.
All the information is then compiled into an initial report, which
is distributed for comment. Once these comments have been discussed
and the appropriate actions taken, the final report is written. I then
present this to the Drugs and Therapeutics Committee for final approval.
Providing the communication process has been successful, this should
be a formality.
Implementation
Assuming that the Drugs and Therapeutic Committee accept the report,
it is my job to co-ordinate the implementation of the approved changes.
This involves informing clinical staff of the decision so they can
adapt their prescribing practices accordingly. Pharmacy staff involved
in procurement also need to know about the changes so that they can
adjust stock levels. Implementation also involves amending paperwork
and the information on the pharmacy computer system and intranet as
appropriate.
As pointed out above, time taken in communicating details about the
potential new policies to trust staff earlier on in the process will
make implementation easier.
Audit
Each change made to the formulary needs to be audited in order to
check that it is being adhered to. This is done by monitoring prescribing
patterns through the pharmacy computer system as an ongoing process
and comparing them with the baseline figures produced earlier. Each
full audit needs to be completed within an agreed time scale (usually
six months from the start of the implementation process).
The drug use evaluation process itself is also to be audited on a yearly
basis, so that continual improvements can be made.
Other activities
Other organisations
Information (including contact
details) about other organisations that have an
interest in antimicrobial resistance can be found in last October’s
edition of
Hospital Pharmacist (2003;10:400) |
Promoting the work of a drug evaluation technician is an important
part of the job, particularly because the role is new and quite an
unusual one for a technician to have. At North Tees and Hartlepool
NHS Trust, this has been done by giving presentations to pharmacy staff
at both hospital sites.
I have also attended externally-organised conferences (such as those
on antimicrobial management that took place at the Royal Pharmaceutical
Society’ headquarters in London last year and earlier on this
year). As well as offering opportunities to promote work, conference
attendance also benefits technicians involved in drug evaluation in
that they are able to learn from the experiences of others and avoid “re-inventing
the wheel”.
Moving forward
Infection management news letter
Barbara Dean, formulary and DUE
pharmacist at North Tees and Hartlepool NHS Trust, manages an email
news group on infection management, as part of the United Kingdom
Clinical Pharmacy
Association Infection Management Group.
Visit www.ukcpa.org or
email barbdean@tiscali.co.uk |
Particularly because it is a new role, my job of drug use evaluation
technician is developing all the time. Because nationally co-ordinated
schemes are being put into place to promote better prescribing, the
work I do on antimicrobial drugs is now being linked in with these.
I am therefore now reviewing the antibiotic policy of certain specialities
(such as, most recently, obstetrics and gynaecology) against current
national guidance, linking with microbiology reports to check for local
resistance. There are also plans to launch trust-wide guidance on intravenous
to oral antibiotic switches, a policy on stating the length of antimicrobial
treatment and a restricted list, so certain antibiotics can be prescribed
only under strict criteria.
The SOPs developed at the trust,
however, are still being used at a local level to analyse the prescribing
patterns relating to drugs other than antimicrobials and, if necessary,
adjust the trusts’ policy and formularies accordingly.
Conclusion
Taking part in national initiatives such as that to promote the better
prescribing of antimicrobials is a good use of a
pharmacy technician’s skills. It means that pharmacy departments
can play a full part in such schemes, without exclusively pharmacists’ time
being spent on them. It also allows technicians to develop careers
that are not entirely dispensary-focused. I value the challenges and
responsibility the role brings me.
“Focus on technician” articles
This series exists to report on how pharmacy technicians
are pushing forward their
traditional boundaries and making a full
contribution to the profession. Any
pharmacist or technician who is is involved in any new developments
in work
undertaken by technicians is asked to
consider writing an article for publication. Advice on the publication
process can be obtained by telephoning Hospital Pharmacist on
020 7572 2425/2419 or e-mailing gareth.jones@pharmj.org.uk |
|